These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24045230)

  • 101. Expressing antigen binding fragments with high titers in a targeted integration CHO host by optimizing expression vector gene copy numbers and position: A case study.
    Tang D; Gunson J; Tran E; Lam C; Shen A; Snedecor B; Barnard G; Misaghi S
    Biotechnol Prog; 2022 Nov; 38(6):e3290. PubMed ID: 36537257
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Ultra Q-bodies: quench-based antibody probes that utilize dye-dye interactions with enhanced antigen-dependent fluorescence.
    Abe R; Jeong HJ; Arakawa D; Dong J; Ohashi H; Kaigome R; Saiki F; Yamane K; Takagi H; Ueda H
    Sci Rep; 2014 Apr; 4():4640. PubMed ID: 24721819
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Rapid generation of high-quality recombinant antibodies using an Expi293F expression system for a 17 β-estradiol immunoassay.
    Lu X; Ye Y; Wang Y; Xu J; Sun J; Ji J; Zhang Y; Sun X
    J Hazard Mater; 2023 Jun; 451():131126. PubMed ID: 36878029
    [TBL] [Abstract][Full Text] [Related]  

  • 104. An effective strategy for the humanization of antibody fragments under an accelerated timeline.
    Jiacomini IG; Beltramino M; Boursin F; Minozzo JC; de Moura JF; Billiald P; Alvarenga LM; Aubrey N
    Int J Biol Macromol; 2022 Sep; 216():465-474. PubMed ID: 35803408
    [TBL] [Abstract][Full Text] [Related]  

  • 105. 704/DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates.
    Colombani T; Haudebourg T; Pitard B
    Mol Ther Nucleic Acids; 2023 Jun; 32():743-757. PubMed ID: 37251693
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Heterologous protein production using euchromatin-containing expression vectors in mammalian cells.
    Zboray K; Sommeregger W; Bogner E; Gili A; Sterovsky T; Fauland K; Grabner B; Stiedl P; Moll HP; Bauer A; Kunert R; Casanova E
    Nucleic Acids Res; 2015 Sep; 43(16):e102. PubMed ID: 25977298
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Development and characterization of anti-IL-5 monoclonal antibody Fab fragment for blocking IL-5/IL-5Rα binding.
    Li S; Wang S; Fordjour E; Liang Y; Wang X; Ye Y; Bai Z; Yang Y; Chen Y
    Int Immunopharmacol; 2023 Nov; 124(Pt B):111032. PubMed ID: 37832239
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Optimization of Mouse-on-Mouse Immunohistochemistry by Utilizing Fluorescent-dye Conjugated Secondary Anti-Mouse Antibody.
    Moein S; Adibi R; Amouheidari A; Gheisari Y
    Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):473-477. PubMed ID: 33958524
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Recent Advancements in AAV-Vectored Immunoprophylaxis in the Nonhuman Primate Model.
    Campbell ESB; Goens MM; Cao W; Thompson B; Susta L; Banadyga L; Wootton SK
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626720
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Expression of soluble recombinant human matrix metalloproteinase 9 and generation of its monoclonal antibody.
    Jeong HJ; Kim EJ; Kim JK; Kim YG; Lee CS; Ko BJ; Kim BG
    Protein Expr Purif; 2021 Nov; 187():105931. PubMed ID: 34197919
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Signature of Antibody Domain Exchange by Native Mass Spectrometry and Collision-Induced Unfolding.
    Watanabe Y; Vasiljevic S; Allen JD; Seabright GE; Duyvesteyn HME; Doores KJ; Crispin M; Struwe WB
    Anal Chem; 2018 Jun; 90(12):7325-7331. PubMed ID: 29757629
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Progress in novel delivery technologies to improve efficacy of therapeutic antibodies.
    Sun W; Wu Y; Ying T
    Antiviral Res; 2024 May; 225():105867. PubMed ID: 38521465
    [TBL] [Abstract][Full Text] [Related]  

  • 113. High titer expression of antibodies using linear expression cassettes for early-stage functional screening.
    Wu S; Tsukuda J; Chiang N; Hao T; Chen Y; Hötzel I; Balasubramanian S; Nakamura G; Kelly RL
    Protein Eng Des Sel; 2024 Jan; 37():. PubMed ID: 39141844
    [TBL] [Abstract][Full Text] [Related]  

  • 114. In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies.
    Patel A; Bah MA; Weiner DB
    BioDrugs; 2020 Jun; 34(3):273-293. PubMed ID: 32157600
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Fast-dissociating but highly specific antibodies are novel tools in biology, especially useful for multiplex super-resolution microscopy.
    Miyoshi T; Friedman TB; Watanabe N
    STAR Protoc; 2021 Dec; 2(4):100967. PubMed ID: 34841279
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Mechanistic modeling of a human IgG
    Wang B; Goodman J; Roskos LK
    CPT Pharmacometrics Syst Pharmacol; 2022 Apr; 11(4):438-446. PubMed ID: 35023315
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A novel Python program for implementation of quality control in the ELISA.
    Wetzel HN; Cohen C; Norman AB; Webster RP
    J Immunol Methods; 2017 Sep; 448():80-84. PubMed ID: 28579365
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Biological Barriers for Drug Delivery and Development of Innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A/B.
    Basar E; Mead H; Shum B; Rauter I; Ay C; Skaletz-Rorowski A; Brockmeyer NH
    Pharmaceutics; 2024 Sep; 16(9):. PubMed ID: 39339243
    [TBL] [Abstract][Full Text] [Related]  

  • 119. IBD: Antibodies to anti-TNF therapy--consequences for IBD management.
    van Deen WK; Hommes DW
    Nat Rev Gastroenterol Hepatol; 2013 Aug; 10(8):446-8. PubMed ID: 23817324
    [No Abstract]   [Full Text] [Related]  

  • 120. Fab-arm exchange: what's in a name?
    Schuurman J; Labrijn AF; Parren PW
    MAbs; 2012; 4(6):636. PubMed ID: 22955209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.